Back

XPO1 gene silencing in heart failure. A new therapeutic strategy

27 August 2016 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Poster session 2 - Cardiac genetics and ageing Genetics and gene therapy ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Esther Rosello-Lleti

Health Research Institute La Fe, Valencia (Spain)

14 More presentations in this session

Presentation thumbnail
Aberrant glycosylation patterns of human arrhythmogenic cardiomyopathy-associated Desmoglein-2 sequence variants
Miss J. Debus (Bad Oeynhausen, DE)
Abstract
Presentation thumbnail
Effect of angiotensin-converting enzyme gene polymorphisms on cardiovascular and renal clinical outcomes in patients with coronary artery disease: 10-years follow-up results
Presentation thumbnail
Association of a polymorphism of the butyrophilin, subfamily 2, member A1 gene with hypertension in community-dwelling Japanese individuals
Doctor Y. Yamase (Tajimi, JP)
Abstract Slides
Presentation thumbnail
Endothelium-dependent vasodilation in patients with neuropathic and neuroischemic forms of diabetic foot syndrome in the treatment methods of cell and gene therapy
Assistant Professor A. Kotslova (Saint Petersburg, RU)
Presentation thumbnail
Additive effects of multiple genetic variants on the risk of coronary artery disease
Professor A. Pereira (Funchal, PT)

Access the full session

Session thumbnail
Poster session 2 - Cardiac genetics and ageing

The Event

Event poster

ESC Congress 2016

27 August - 31 August 2016

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources